Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

iKang Healthcare to IPO in the US

publication date: Mar 3, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
iKang Healthcare Group filed for a $150 million IPO on the NASDAQ exchange in the US. iKang, based in Beijing, claims to have the largest share of the private medical service sector in China, about 11% in 2012. It operates through 42 medical centers in China’s largest 13 cities. The centers are on track to provide diagnostic services to nearly 3 million clients in fiscal 2013. The company has also established relationships with 300 third-party service providers to extend its geographical reach. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



ChinaBio® Events
Suzhou, China
May 18 - 19, 2016
Record attendance of 1008!
See us next year in Shunde!

>> More events...

Other Events
Hong Kong, China
June 15–17, 2016
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors